15 minutes delayed
IMMUNOGEN INC COM reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of IMMUNOGEN INC COM using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2023 | 2023-11-02 | $0.10 | $0.04 | 150.0 % |
Jun 2023 | 2023-07-31 | $-0.02 | $-0.16 | 87.5 % |
Mar 2023 | 2023-04-28 | $-0.16 | $-0.25 | 36.0 % |
Dec 2022 | 2023-03-01 | $-0.23 | $-0.30 | 23.3 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2023 | 2023-11-02 | $113.43M | $106.04M | 6.96 % |
Jun 2023 | 2023-07-31 | $83.15M | $42.84M | 94.1 % |
Mar 2023 | 2023-04-28 | $49.87M | $20.47M | 143.6 % |
Dec 2022 | 2023-03-01 | $41.17M | $17.23M | 138.9 % |
IMMUNOGEN INC COM (IMGN) is scheduled to report earnings on October 31, 2024. The last reported earnings were for reported on November 2, 2023 for Q3.
The Actual EPS was $0.10, which beat the estimate of $0.04.
The Actual Revenue was $113.4M, which beat the estimate of $106M.
Browse earnings estimates, EPS, and revenue on all stocks.